Homoharringtonine as a PHGDH inhibitor: Unraveling metabolic dependencies and developing a potent therapeutic strategy for high-risk neuroblastoma.
Biomed Pharmacother
; 166: 115429, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37673018
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phosphoglycerate Dehydrogenase
/
Neuroblastoma
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Biomed Pharmacother
Year:
2023
Document type:
Article